Literature DB >> 14739306

T2-weighted MR imaging in the assessment of cirrhotic liver.

Hero K Hussain1, Ibrahim Syed, Hanh V Nghiem, Timothy D Johnson, Ruth C Carlos, William J Weadock, Isaac R Francis.   

Abstract

PURPOSE: To assess if T2-weighted magnetic resonance (MR) imaging provides added diagnostic value in combination with dynamic gadolinium-enhanced MR imaging in the detection and characterization of nodular lesions in cirrhotic liver.
MATERIALS AND METHODS: Two readers retrospectively and independently analyzed 54 MR imaging studies in 52 patients with cirrhosis. In session 1, readers reviewed T1-weighted and dynamic gadolinium-enhanced images. In session 2, readers reviewed T1-weighted, dynamic gadolinium-enhanced, and respiratory-triggered T2-weighted fast spin-echo images. Readers identified and characterized all focal lesions by using a scale of 1-4 (1, definitely benign; 4, definitely malignant). Multireader correlated receiver operating characteristic (ROC) analysis was employed to assess radiologist performance in session 2 compared with session 1. The difference in the areas under the ROC curves for the two sessions was tested. In a third session, readers assessed conspicuity of biopsy-proved lesions on T2-weighted MR images by using a scale of 1-3 (1, not seen; 3, well seen) and identified causes of reduced conspicuity.
RESULTS: Two additional benign lesions were detected by each reader in session 2. Fifty-five lesions had pathologic verification, including 32 malignant, three high-grade dysplastic, and 20 benign nodules. There was no significant difference in the area under the ROC curves between the two sessions (P =.48). Thirty-two lesions were inconspicuous on T2-weighted MR images because of parenchymal heterogeneity, breathing artifacts (particularly in patients with ascites), and lesion isointensity with liver parenchyma. T2-weighted MR imaging was useful in the evaluation of cysts and lymph nodes.
CONCLUSION: T2-weighted MR imaging does not provide added diagnostic value in the detection and characterization of focal lesions in cirrhotic liver. Copyright RSNA, 2004

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14739306     DOI: 10.1148/radiol.2303020921

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  17 in total

1.  Added value of hepatobiliary phase gadoxetic acid-enhanced MRI for diagnosing hepatocellular carcinoma in high-risk patients.

Authors:  Sith Phongkitkarun; Kuruwin Limsamutpetch; Penampai Tannaphai; Janjira Jatchavala
Journal:  World J Gastroenterol       Date:  2013-12-07       Impact factor: 5.742

2.  Diffusion-weighted images (DWI) without ADC values in assessment of small focal nodules in cirrhotic liver.

Authors:  Mai-Lin Chen; Xiao-Yan Zhang; Li-Ping Qi; Qing-Lei Shi; Bin Chen; Ying-Shi Sun
Journal:  Chin J Cancer Res       Date:  2014-02       Impact factor: 5.087

Review 3.  Current opinion on the role of resection and liver transplantation for hepatocellular cancer.

Authors:  P Puneet; M T P R Perera; Darius F Mirza
Journal:  Indian J Gastroenterol       Date:  2012-06-19

4.  Vascular invasion in hepatocellular carcinoma: is there a correlation with MRI?

Authors:  N Griffin; H Addley; E Sala; A S Shaw; L A Grant; H Eldaly; S E Davies; T Prevost; G J Alexander; D J Lomas
Journal:  Br J Radiol       Date:  2011-03-08       Impact factor: 3.039

Review 5.  Morphological, dynamic and functional characteristics of liver pseudolesions and benign lesions.

Authors:  Matteo Renzulli; Nicolò Brandi; Giulia Argalia; Stefano Brocchi; Andrea Farolfi; Stefano Fanti; Rita Golfieri
Journal:  Radiol Med       Date:  2022-01-13       Impact factor: 3.469

6.  Non-alcoholic fatty liver disease-associated hepatocellular carcinoma: effect of hepatic steatosis on major hepatocellular carcinoma features at MRI.

Authors:  Scott M Thompson; Ishan Garg; Eric C Ehman; Shannon P Sheedy; Candice A Bookwalter; Rickey E Carter; Lewis R Roberts; Sudhakar K Venkatesh
Journal:  Br J Radiol       Date:  2018-08-29       Impact factor: 3.039

7.  MRI characterization of 124 CT-indeterminate focal hepatic lesions: evaluation of clinical utility.

Authors:  Khaled M Elsayes; John R Leyendecker; Christine O Menias; Erica P Oliveira; Vamsidhar R Narra; William C Chapman; Moataz H Hassanien; Mohamed S Elsharkawy; Jeffrey J Brown
Journal:  HPB (Oxford)       Date:  2007       Impact factor: 3.647

8.  Noninvasive classification of hepatic fibrosis based on texture parameters from double contrast-enhanced magnetic resonance images.

Authors:  Gautam Bahl; Irene Cruite; Tanya Wolfson; Anthony C Gamst; Julie M Collins; Alyssa D Chavez; Fatma Barakat; Tarek Hassanein; Claude B Sirlin
Journal:  J Magn Reson Imaging       Date:  2012-07-31       Impact factor: 4.813

9.  T2-Weighted Liver MRI Using the MultiVane Technique at 3T: Comparison with Conventional T2-Weighted MRI.

Authors:  Kyung A Kang; Young Kon Kim; EunJu Kim; Woo Kyoung Jeong; Dongil Choi; Won Jae Lee; Sin-Ho Jung; Sun-Young Baek
Journal:  Korean J Radiol       Date:  2015-08-21       Impact factor: 3.500

Review 10.  Imaging of hepatocellular carcinoma: diagnosis, staging and treatment monitoring.

Authors:  Tiffany Hennedige; Sudhakar Kundapur Venkatesh
Journal:  Cancer Imaging       Date:  2013-02-08       Impact factor: 3.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.